Tuesday, Oct 19, 2021 | Last Update : 08:52 PM IST


AbbVie to buy Botox-maker Allergan in USD 63 billion deal

Allergan shareholders will receive 0.8660 AbbVie shares and USD 120.30 in cash for each share held.

25 Jun 2019 4:43 PM

AbbVie rheumatoid arthritis drug succeeds in late stage trial

The U.S. drugmaker hopes the drug, upadacitinib, can help replace lost revenue from its top-selling RA treatment Humira.

24 Oct 2018 11:15 AM